Endoscopic Ultrasound Market Size & Share 2024 – 2032

Endoscopic Ultrasound Market Size

Endoscopic Ultrasound Market size was valued at USD 1.2 billion in 2023 and is anticipated to witness a CAGR of 6.9% from 2024 to 2032. The endoscopic ultrasound (EUS) market is experiencing growth driven by the rising incidence of gastrointestinal diseases, favorable reimbursement policies, and increasing demand for minimally invasive procedures.

Gastrointestinal diseases, which include conditions such as colorectal cancer, pancreatitis, inflammatory bowel disease (IBD), and gastrointestinal bleeding, are becoming increasingly prevalent worldwide. For instance, according to an article published by The Lancet in 2024, conservative estimates predict more than 10 million new IBD cases in regions such as Asia, South America, Eastern Europe, and Africa by 2050. The incidence of IBD is rapidly accelerating in these areas. This surge in cases is driven by factors such as aging populations, changes in dietary habits, and lifestyle-related risk factors, leading to greater demand for advanced gastrointestinal diagnostics.
 

Additionally, favorable reimbursement policies for EUS procedures in many regions support market growth by making these advanced diagnostic and therapeutic options more affordable for patients. The economic burden of untreated or late-diagnosed gastrointestinal diseases, which can lead to higher healthcare costs and lower quality of life, highlights the value of investing in early and accurate diagnostic tools like EUS.
 

Endoscopic ultrasound is a medical procedure that combines endoscopy and ultrasound to obtain detailed images and information about the digestive tract and surrounding tissues and organs. This procedure provides high-resolution images that aid in the accurate diagnosis and management of various gastrointestinal conditions.
 

Endoscopic Ultrasound Market Trends

The continuous development and integration of new technologies have significantly enhanced the capabilities and applications of EUS, making it a more effective and versatile tool for diagnosing and treating gastrointestinal and other related diseases. These advancements have not only improved the quality of imaging and diagnostic accuracy but have also expanded the therapeutic potential of EUS, driving its adoption in clinical practice.
 

• High-frequency ultrasound probes and advanced imaging software have greatly increased the resolution and clarity of images obtained during EUS procedures. This allows for more detailed visualization of the gastrointestinal tract and surrounding structures, leading to more accurate diagnoses and better-informed treatment decisions.
   
• Additionally, the integration of fine-needle aspiration (FNA) with EUS has been a major technological milestone. EUS-guided FNA enables the collection of tissue samples from lesions or lymph nodes that are not easily accessible through other imaging modalities.
   
• This combination has significantly improved the ability to diagnose and stage cancers and other diseases, facilitating targeted and personalized treatment plans. The precision and minimally invasive nature of EUS-FNA have made it a valuable tool in clinical practice.
   
• Furthermore, the miniaturization of EUS equipment and the development of portable ultrasound devices have increased the accessibility and usability of EUS in various clinical settings. Portable EUS systems allow for point-of-care diagnostics and treatments, making EUS available in outpatient clinics, smaller hospitals, and even in remote areas.
   
• This has broadened the reach of EUS, making advanced diagnostic and therapeutic procedures available to a wider patient population, contributing to the market’s expansion.
   

Endoscopic Ultrasound Market Analysis

Based on component, the market is segmented into endoscope, needle, ultrasonic processors, imaging systems, ultrasound probe, and other components. The endoscope segment held a dominant market share of 32.1% in 2023.
 

• Endoscopes used in EUS are indispensable tools for a wide range of diagnostic and therapeutic applications. They enable the detailed examination of the gastrointestinal mucosa, submucosa, and adjacent structures, facilitating the early detection of conditions such as pancreatic cancer, esophageal cancer, and other gastrointestinal disorders.
   
• Additionally, modern endoscopes are designed with patient comfort and safety in mind. Features such as improved maneuverability, ergonomic designs, and reduced insertion diameters contribute to a more comfortable experience for patients undergoing EUS procedures. The emphasis on patient-centred care and the development of endoscopes that minimize discomfort and enhance safety have contributed to their widespread acceptance and use in medical settings.
   

Based on application, the endoscopic ultrasound market is classified into oncology, gastroenterology, and other applications. The oncology segment accounted for the highest market share and is estimated to be valued at USD 1.4 billion by 2032.
 

• The rising incidence of gastrointestinal cancers, including esophageal, gastric, pancreatic, and colorectal cancers, significantly drives the demand for EUS in oncology. For instance, according to the World Cancer Research Foundation, there were 1,926,425 new cases of colorectal around the world cancer in 2022. EUS is essential for the early detection, staging, and evaluation of these cancers, enabling more effective treatment planning and improved patient outcomes. As cancer rates continue to increase globally, the oncology segment's reliance on EUS technology grows correspondingly.
   
• Additionally, EUS provides high-resolution images and detailed visualization of the gastrointestinal tract and surrounding structures, making it an invaluable tool for early and accurate cancer diagnosis. The ability of EUS to identify small lesions and determine the extent of tumor invasion is crucial for staging cancers and planning appropriate treatments. Early detection through EUS can significantly improve prognosis and survival rates for cancer patients. These proven clinical benefits solidify their dominant position in the market.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on end-use, the endoscopic ultrasound market is categorized into hospitals, ambulatory surgical centers, and other end-users. The hospitals segment is projected to reach USD 1.4 billion by 2032.
 

• Hospitals dominate the EUS market primarily in diagnostic procedures due to their comprehensive infrastructure and specialized medical teams. They offer a wide range of diagnostic services using EUS, including staging of gastrointestinal cancers, evaluation of pancreatic and biliary diseases, and assessment of submucosal lesions. The availability of integrated facilities allows hospitals to perform EUS with precision and efficiency, thereby enhancing patient outcomes.
   
• Additionally, beyond diagnostics, hospitals lead in therapeutic interventions utilizing EUS technology. These interventions include fine-needle aspiration (FNA) for tissue sampling, drainage of pseudocysts and abscesses, celiac plexus neurolysis for pain management in pancreatic cancer, and EUS-guided delivery of therapeutic agents. Hospitals leverage their multidisciplinary teams comprising gastroenterologists, interventional radiologists, and oncologists to provide comprehensive care using EUS for therapeutic purposes.
   

North America endoscopic ultrasound market size in 2023 was valued at USD 501.8 million and is predicted to grow at a CAGR of 6.3% over the analysis timeframe.
 

• North America holds a prominent position in the global EUS market, driven by robust healthcare infrastructure, high adoption rates of advanced medical technologies, and substantial investments in research and development.
   
• The region is characterized by a strong presence of leading healthcare providers and academic institutions specializing in gastrointestinal and oncological care.
   
• Continuous technological advancements in EUS systems, including improved imaging resolution, enhanced ergonomics, and integration with other diagnostic modalities, contribute to North America's leadership in the market.
   
• These innovations enable healthcare providers to offer precise diagnostics and effective therapeutic interventions, thereby bolstering market growth.
   

The U.S. endoscopic ultrasound market is anticipated to grow at a CAGR of 6.2% to reach USD 797.1 million by 2032.
 

• Stringent regulatory standards and comprehensive reimbursement policies in the U.S. support the widespread adoption of EUS procedures. Clear guidelines ensure patient safety and quality assurance, fostering confidence among healthcare professionals and patients alike.
   
• Additionally, the U.S. leads in the utilization of EUS across various clinical applications, such as the staging of gastrointestinal malignancies, evaluation of pancreatic and biliary diseases, and targeted therapies for pancreatic cancer. These applications highlight the country’s capability to leverage EUS technology for comprehensive patient care.
   

France endoscopic ultrasound market is projected to grow remarkably in the coming years.
 

• France is recognized for its contributions to EUS research and development, with several renowned medical centers and academic institutions pioneering advancements in the field. This leadership fosters a culture of innovation and drives the adoption of EUS technology across clinical settings.
   
• French healthcare facilities excel in integrating EUS into clinical practice, particularly in oncology and gastroenterology. The country's healthcare system emphasizes multidisciplinary collaboration, enabling comprehensive patient management through EUS-guided diagnostics and therapeutic procedures.
   

Japan is experiencing high market growth in the endoscopic ultrasound market.
 

• Japanese healthcare providers demonstrate proficiency in performing intricate EUS procedures, such as fine-needle aspiration and therapeutic interventions for gastrointestinal and pancreatic disorders. The integration of EUS into clinical practice reflects Japan commitment to achieving optimal patient outcomes through precision medicine.
   
• Additionally, Japan regulatory environment supports the introduction and commercialization of innovative medical devices, ensuring compliance with rigorous standards of safety and efficacy. This regulatory framework facilitates market growth and sustains Japan notable share in the global EUS market.
   

Endoscopic Ultrasound Market Share

The endoscopic ultrasound industry is characterized by the presence of several established and emerging players that offer a variety of products across the globe. The market players compete based on factors such as product quality, innovation, regulatory compliance, customer service, and pricing strategies.
 

Endoscopic Ultrasound Market Companies

Prominent players operating in the endoscopic ultrasound industry include:

• B.Braun
• Boston Scientific Corporation
• ConMed
• Cook Medical
• FUJIFILM Holdings Corporation 
• HUACO HEALTHCARE TECHNOLOGIES CO. LTD
• Medi-Globe Corporation
• Medtronic plc
• NIHON DEMPA KOGYO CO., LTD.
• PENTAX Medical
• Philips
• SMITH & NEPHEW
• SonoScape Medical Corp.
• STERIS plc
   

Endoscopic Ultrasound Industry News:

• In February 2024, Fujifilm announced the launch of the ALOKA ARIETTA 850 diagnostic ultrasound system in India. This system also incorporates HD-THI for deeper penetration, ensuring accurate diagnoses, along with combi-elastography, pure symphonic architecture, and CHI-TIC and inflow time mapping for clearer visibility by reducing noise and enhancing the completeness and continuity of tissue boundaries. This product launch may help the company enhance diagnostic precision imaging capabilities in the region.
   

The endoscopic ultrasound market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 - 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Component

• Endoscope
  • Linear endoscopes
  • Radial endoscopes
• Needle
  • Fine needle aspiration (FNA) needles
  • Fine needle biopsy (FNB) needles
• Ultrasonic processors
• Imaging systems
• Ultrasound probe
• Other components

Market, By Application

• Oncology
• Gastroenterology
• Other applications

Market, By End-use

• Hospitals
• Ambulatory surgical centers
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa